LENZ logo

LENZ Therapeutics (LENZ) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 1, 2022

Total Assets

$224.0 M(+10.5%)$202.6 M(-6.8%)$217.3 M(+208.8%)$70.4 M(-23.6%)$92.2 M--$47.0 M

Current Assets

$220.7 M(+10.7%)$199.3 M(-8.0%)$216.7 M(+222.2%)$67.2 M(-25.2%)$89.9 M--$46.6 M

Non Current Assets

$3.3 M(+0.4%)$3.3 M(+407.6%)$648.0 K(-79.3%)$3.1 M(+36.4%)$2.3 M--$310.0 K

Total Liabilities

$8.7 M(-10.2%)$9.7 M(-49.3%)$19.2 M(-88.3%)$163.1 M(+0.8%)$161.7 M--$71.1 M

Current Liabilities

$7.7 M(-10.2%)$8.6 M(-54.6%)$18.9 M(+2.0%)$18.5 M(+9.9%)$16.8 M--$9.5 M

Long Term Liabilities

$1.0 M(-10.4%)$1.1 M(+325.1%)$267.0 K(-99.8%)$144.6 M(-0.2%)$144.9 M--$61.6 M

Shareholders Equity

$215.3 M(+11.6%)$192.9 M(-2.6%)$198.2 M(+313.7%)-$92.7 M(-33.3%)-$69.6 M---$24.2 M

Book Value

$215.3 M(+11.6%)$192.9 M(-2.6%)$198.2 M(+313.7%)-$92.7 M(-33.3%)-$69.6 M---$24.2 M

Working Capital

$213.0 M(+11.7%)$190.8 M(-3.5%)$197.8 M(+305.9%)$48.7 M(-33.3%)$73.0 M--$37.1 M

Cash And Cash Equivalents

$41.0 M(-51.2%)$84.0 M(-58.1%)$200.4 M(+470.2%)$35.1 M(-18.0%)$42.8 M--$44.4 M

Accounts Payable

$2.8 M(-37.3%)$4.4 M(-38.2%)$7.1 M(+24.9%)$5.7 M(+10.9%)$5.1 M--$4.8 M

Accounts Receivable

--------

Short Term Debt

$625.0 K(-3.7%)$649.0 K(+49.9%)$433.0 K(+216.1%)$137.0 K(+3.0%)$133.0 K--$103.0 K

Long Term Debt

$953.0 K(-9.4%)$1.1 M(+574.4%)$156.0 K(-18.8%)$192.0 K(-15.4%)$227.0 K--$147.0 K

Total Debt

$1.6 M(-7.2%)$1.7 M(+188.8%)$589.0 K(+79.0%)$329.0 K(-8.6%)$360.0 K(+100.0%)$0.0(0%)$0.0(-100.0%)$250.0 K

Debt To Equity

0.0(0%)0.0(+100.0%)0.0(0%)0.0(+100.0%)-0.0---0.0

Current Ratio

28.6(+23.3%)23.2(+102.5%)11.5(+216.0%)3.6(-32.0%)5.3--4.9

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$132.4 M(-213387.1%)-$62.0 K(+99.9%)-$111.9 M(-17.5%)-$95.2 M(-33.1%)-$71.6 M---$25.3 M

PB Ratio

3.0(+30.6%)2.3(-19.2%)2.9-----

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 1, 2022

EPS

-$0.4(+5.0%)-$0.4(+88.7%)-$3.5(-280.4%)-$0.9(-25.5%)-$0.7(-28.2%)-$0.6(-16.2%)-$0.5(-34.4%)-$0.4

TTM EPS

-$5.2(+6.4%)-$5.6(+3.1%)-$5.8(-110.7%)-$2.7(-25.6%)-$2.2(-51.3%)-$1.4(-66.6%)-$0.9(-134.4%)-$0.4

Revenue

--------

TTM Revenue

--------

Total Expenses

$12.9 M(-9.8%)$14.4 M(-10.8%)$16.1 M(-35.6%)$25.0 M(+25.8%)$19.9 M(+32.8%)$15.0 M(+18.6%)$12.6 M(+38.2%)$9.1 M

Operating Expenses

$12.9 M(-9.8%)$14.4 M(-10.8%)$16.1 M(-35.6%)$25.0 M(+25.8%)$19.9 M(+32.8%)$15.0 M(+18.6%)$12.6 M(+38.2%)$9.1 M

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$12.9 M(+9.8%)-$14.4 M(+10.8%)-$16.1 M(+35.6%)-$25.0 M(-25.8%)-$19.9 M(-32.8%)-$15.0 M(-18.6%)-$12.6 M(-38.2%)-$9.1 M

TTM Operating Profit

-$68.4 M(+9.2%)-$75.3 M(+0.8%)-$75.9 M(-4.8%)-$72.4 M(-28.0%)-$56.6 M(-54.1%)-$36.7 M(-68.8%)-$21.7 M(-138.2%)-$9.1 M

Operating Margin

--------

Net Income

-$10.2 M(+0.4%)-$10.3 M(+38.4%)-$16.6 M(+29.7%)-$23.7 M(-25.5%)-$18.9 M(-28.2%)-$14.7 M(-16.2%)-$12.7 M(-34.4%)-$9.4 M

TTM Net Income

-$60.8 M(+12.5%)-$69.5 M(+6.0%)-$73.9 M(-5.7%)-$70.0 M(-25.6%)-$55.7 M(-51.3%)-$36.8 M(-66.6%)-$22.1 M(-134.4%)-$9.4 M

Net Margin

--------

EBIT

-$12.9 M(+9.8%)-$14.4 M(+10.8%)-$16.1 M(+35.6%)-$25.0 M(-25.8%)-$19.9 M(-32.8%)-$15.0 M(-18.6%)-$12.6 M(-38.2%)-$9.1 M

TTM EBIT

-$68.4 M(+9.2%)-$75.3 M(+0.8%)-$75.9 M(-4.8%)-$72.4 M(-28.0%)-$56.6 M(-54.1%)-$36.7 M(-68.8%)-$21.7 M(-138.2%)-$9.1 M

EBITDA

-$12.9 M(+9.8%)-$14.3 M(+10.9%)-$16.1 M(+35.6%)-$25.0 M(-25.8%)-$19.9 M(-32.8%)-$15.0 M(-18.6%)-$12.6 M(-38.2%)-$9.1 M

TTM EBITDA

-$68.3 M(+9.2%)-$75.3 M(+0.8%)-$75.9 M(-4.8%)-$72.4 M(-28.1%)-$56.6 M(-54.1%)-$36.7 M(-68.8%)-$21.7 M(-138.2%)-$9.1 M

Selling, General & Administrative Expenses

$6.5 M(-12.3%)$7.4 M(+33.4%)$5.6 M(+1.8%)$5.5 M(+90.6%)$2.9 M(+23.3%)$2.3 M(+1.3%)$2.3 M(+53.0%)$1.5 M

TTM SGA

$24.9 M(+17.1%)$21.3 M(+31.4%)$16.2 M(+25.2%)$12.9 M(+44.1%)$9.0 M(+46.8%)$6.1 M(+61.3%)$3.8 M(+153.0%)$1.5 M

Depreciation And Amortization

$10.0 K(-44.4%)$18.0 K(+260.0%)$5000.0(+25.0%)$4000.0(0%)$4000.0(0%)$4000.0(+33.3%)$3000.0-

TTM D&A

$37.0 K(+19.4%)$31.0 K(+82.3%)$17.0 K(+13.3%)$15.0 K(+36.4%)$11.0 K(+57.1%)$7000.0(+133.3%)$3000.0-

Interest Expense

--------

TTM Interest Expense

--------

Income Tax

----$179.0 K---$303.0 K

TTM Income Tax

----$179.0 K---$303.0 K

PE Ratio

--------

PS Ratio

--------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 1, 2022

Cash From Operations

-$10.6 M(+33.0%)-$15.8 M(+34.0%)-$23.9 M(-14.2%)-$21.0 M(-60.2%)-$13.1 M(+3.2%)-$13.5 M(-5.7%)-$12.8 M-

TTM CFO

-$71.3 M(+3.4%)-$73.8 M(-3.2%)-$71.5 M(-18.4%)-$60.4 M(-53.2%)-$39.4 M(-49.7%)-$26.3 M(-105.7%)-$12.8 M-

Cash From Investing

-$62.2 M(+36.8%)-$98.4 M(-646.6%)$18.0 M(+18.6%)$15.2 M(+184.7%)-$17.9 M(+33.4%)-$26.9 M(-447816.7%)-$6000.0-

TTM CFI

-$127.4 M(-53.3%)-$83.1 M(-615.7%)-$11.6 M(+60.8%)-$29.6 M(+33.9%)-$44.8 M(-66.6%)-$26.9 M(-447916.7%)-$6000.0-

Cash From Financing

$29.8 M(+1495.3%)-$2.1 M(-101.3%)$171.3 M(+9062.2%)-$1.9 M(-236.4%)-$568.0 K(-100.0%)$0.0(-100.0%)$83.2 M-

TTM CFF

$197.0 M(+18.2%)$166.7 M(-1.3%)$168.8 M(+109.2%)$80.7 M(-2.3%)$82.6 M(-0.7%)$83.2 M(0%)$83.2 M-

Free Cash Flow

-$10.8 M(+32.4%)-$15.9 M(+33.5%)-$23.9 M(-14.2%)-$21.0 M(-60.2%)-$13.1 M(+3.4%)-$13.5 M(-5.8%)-$12.8 M-

TTM FCF

-$71.6 M(+3.1%)-$73.9 M(-3.3%)-$71.5 M(-18.4%)-$60.4 M(-53.2%)-$39.4 M(-49.7%)-$26.4 M(-105.8%)-$12.8 M-

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------